Based on the 2011 St Gallen consensus, there are four subtypes of BC: luminal, luminal–HER2, HER2-rich, and triple-negative on the basis of the immunohistochemistry results of ER, PR, and HER2 [3]. This evidence concerns the gene ERBB2 and breast cancer.